MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Prostate
NxThera
Organization & Developments: NxThera
Parents
NxThera
Children
Endourologic conditions such as BPH, prostate cancer and kidney cancer affect a significant number of men each year.
More than 12 million men in the U.S. have been diagnosed with BPH and more than 70 percent of men over age 60 experience symptoms of BPH.
More than 2.5 million men in the U.S. have been diagnosed with prostate cancer.
NxThera is developing a thermal vapor prostate treatment
NxThera’s sterile water vapor, or steam, technology platform enables the delivery of targeted, precise BPH treatments in a simple, office-based procedure designed to take only minutes, with minimal discomfort, and provide improvements in urine flow and imp
NxThera’s technology is meant to inject hot vapor into an enlarged prostate in order to shrink it so it stops obstructing the urinary tract.
Jumps
*Key People: NxThera
Finance & Acquisitions: NxThera